{
    "Trade/Device Name(s)": [
        "Tina-Quant Hemoglobin A1c Gen.2 Test",
        "Tina-Quant Hemoglobin A1c Gen.2",
        "Hemoglobin A1c test"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K052464",
    "Predicate Device Reference 510(k) Number(s)": [
        "K934070"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "September 30, 2005",
    "Summary Letter Received Date": "September 8, 2005",
    "Submission Date": "September 7, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Capillary blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Integra 800",
        "Automated analyzers including Hitachi family"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric inhibition immunoassay (TINIA)",
        "Bichromatic photometry"
    ],
    "Methodologies": [
        "Immunoassay",
        "Photometric determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent System"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Tina-Quant Hemoglobin A1c Gen.2 test for quantitative determination of percent hemoglobin A1c in whole blood.",
    "Indications for Use Summary": "Intended for quantitative determination of percent hemoglobin A1c in whole blood to monitor long-term blood glucose control in individuals with diabetes mellitus.",
    "fda_folder": "Hematology"
}